Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting()()()

BACKGROUND: To evaluate the efficacy and toxicities of regorafenib plus irinotecan, dose-escalated on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping, in previously heavily treated metastatic colorectal cancer (mCRC) and the prognostic values of EGFR expression, KRAS...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Oncol
Hoofdauteurs: Ma, Cheng-Jen, Huang, Ching-Wen, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Su, Wei-Chih, Yeh, Yung-Sung, Chen, Po-Jung, Wang, Jaw-Yuan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Neoplasia Press 2018
Onderwerpen:
Original article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307535/
https://ncbi.nlm.nih.gov/pubmed/30594039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.12.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items